Teriparatide administration by the Omnipod pump: preliminary experience from two cases with refractory hypoparathyroidism.
Karine AouchicheRachel ReynaudVincent AmodruThierry BrueThomas CunyPublished in: Endocrine (2022)
Continuous administration of teriparatide through Omnipod® appears as an efficient therapeutic option in refractory hypoPTH, whose administration to the patient can be assisted by medically-supervised protocol.